56 related articles for article (PubMed ID: 9545805)
1. [Constitutive activation of MAP kinase pathway and STAT pathway in AML].
Towatari M; Iida H
Rinsho Ketsueki; 1998 Feb; 39(2):86-8. PubMed ID: 9545805
[No Abstract] [Full Text] [Related]
2. STAT3-mediated differentiation and survival and of myeloid cells in response to granulocyte colony-stimulating factor: role for the cyclin-dependent kinase inhibitor p27(Kip1).
de Koning JP; Soede-Bobok AA; Ward AC; Schelen AM; Antonissen C; van Leeuwen D; Löwenberg B; Touw IP
Oncogene; 2000 Jul; 19(29):3290-8. PubMed ID: 10918585
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-6 and oncostatin M-induced growth inhibition of human A375 melanoma cells is STAT-dependent and involves upregulation of the cyclin-dependent kinase inhibitor p27/Kip1.
Kortylewski M; Heinrich PC; Mackiewicz A; Schniertshauer U; Klingmüller U; Nakajima K; Hirano T; Horn F; Behrmann I
Oncogene; 1999 Jun; 18(25):3742-53. PubMed ID: 10391682
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-6 dependent induction of the cyclin dependent kinase inhibitor p21WAF1/CIP1 is lost during progression of human malignant melanoma.
Flørenes VA; Lu C; Bhattacharya N; Rak J; Sheehan C; Slingerland JM; Kerbel RS
Oncogene; 1999 Jan; 18(4):1023-32. PubMed ID: 10023678
[TBL] [Abstract][Full Text] [Related]
5. Cdk pathway: cyclin-dependent kinases and cyclin-dependent kinase inhibitors.
Gitig DM; Koff A
Methods Mol Biol; 2000; 142():109-23. PubMed ID: 10806617
[No Abstract] [Full Text] [Related]
6. JAK3, STAT, and MAPK signaling pathways as novel molecular targets for the tyrphostin AG-490 regulation of IL-2-mediated T cell response.
Wang LH; Kirken RA; Erwin RA; Yu CR; Farrar WL
J Immunol; 1999 Apr; 162(7):3897-904. PubMed ID: 10201908
[TBL] [Abstract][Full Text] [Related]
7. STAT3 activation accompanies keratinocyte differentiation.
Hauser PJ; Agrawal D; Hackney J; Pledger WJ
Cell Growth Differ; 1998 Oct; 9(10):847-55. PubMed ID: 9790496
[TBL] [Abstract][Full Text] [Related]
8. Endothelial receptor tyrosine kinases activate the STAT signaling pathway: mutant Tie-2 causing venous malformations signals a distinct STAT activation response.
Korpelainen EI; Kärkkäinen M; Gunji Y; Vikkula M; Alitalo K
Oncogene; 1999 Jan; 18(1):1-8. PubMed ID: 9926914
[TBL] [Abstract][Full Text] [Related]
9. The cyclin-dependent kinase inhibitor (CDKI) flavopiridol disrupts phorbol 12-myristate 13-acetate-induced differentiation and CDKI expression while enhancing apoptosis in human myeloid leukemia cells.
Cartee L; Wang Z; Decker RH; Chellappan SP; Fusaro G; Hirsch KG; Sankala HM; Dent P; Grant S
Cancer Res; 2001 Mar; 61(6):2583-91. PubMed ID: 11289135
[TBL] [Abstract][Full Text] [Related]
10. Role of c-myc regulation in Zta-mediated induction of the cyclin-dependent kinase inhibitors p21 and p27 and cell growth arrest.
Rodriguez A; Jung EJ; Yin Q; Cayrol C; Flemington EK
Virology; 2001 Jun; 284(2):159-69. PubMed ID: 11384216
[TBL] [Abstract][Full Text] [Related]
11. Expression of signal transducers and activators of transcription proteins in acute myeloid leukemia blasts.
Xia Z; Baer MR; Block AW; Baumann H; Wetzler M
Cancer Res; 1998 Jul; 58(14):3173-80. PubMed ID: 9679986
[TBL] [Abstract][Full Text] [Related]
12. Posttranslational mechanisms contribute to the suppression of specific cyclin:CDK complexes by all-trans retinoic acid in human bronchial epithelial cells.
Sueoka N; Lee HY; Walsh GL; Hong WK; Kurie JM
Cancer Res; 1999 Aug; 59(15):3838-44. PubMed ID: 10447003
[TBL] [Abstract][Full Text] [Related]
13. Differential constitutive activation between STAT-related proteins and MAP kinase in primary acute myelogenous leukaemia.
Hayakawa F; Towatari M; Iida H; Wakao H; Kiyoi H; Naoe T; Saito H
Br J Haematol; 1998 Jun; 101(3):521-8. PubMed ID: 9633897
[TBL] [Abstract][Full Text] [Related]
14. STAT activation by the PDGF receptor requires juxtamembrane phosphorylation sites but not Src tyrosine kinase activation.
Sachsenmaier C; Sadowski HB; Cooper JA
Oncogene; 1999 Jun; 18(24):3583-92. PubMed ID: 10380880
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-9 (IL-9) induces cell growth arrest associated with sustained signal transducer and activator of transcription activation in lymphoma cells overexpressing the IL-9 receptor.
Demoulin JB; Van Snick J; Renauld JC
Cell Growth Differ; 2001 Mar; 12(3):169-74. PubMed ID: 11306517
[TBL] [Abstract][Full Text] [Related]
16. Cell biology. Two major signaling pathways meet at MAP-kinase.
Barinaga M
Science; 1995 Sep; 269(5231):1673. PubMed ID: 7569891
[No Abstract] [Full Text] [Related]
17. Prognostic significance of the cell cycle inhibitor p27Kip1 in acute myeloid leukemia.
Yokozawa T; Towatari M; Iida H; Takeyama K; Tanimoto M; Kiyoi H; Motoji T; Asou N; Saito K; Takeuchi M; Kobayashi Y; Miyawaki S; Kodera Y; Ohno R; Saito H; Naoe T
Leukemia; 2000 Jan; 14(1):28-33. PubMed ID: 10637473
[TBL] [Abstract][Full Text] [Related]
18. A temporal and biochemical link between growth factor-activated MAP kinases, cyclin D1 induction and cell cycle entry.
Lavoie JN; Rivard N; L'Allemain G; Pouysségur J
Prog Cell Cycle Res; 1996; 2():49-58. PubMed ID: 9552382
[TBL] [Abstract][Full Text] [Related]
19. Cytokine signaling through Stat3 activates integrins, promotes adhesion, and induces growth arrest in the myeloid cell line 32D.
Wooten DK; Xie X; Bartos D; Busche RA; Longmore GD; Watowich SS
J Biol Chem; 2000 Aug; 275(34):26566-75. PubMed ID: 10858439
[TBL] [Abstract][Full Text] [Related]
20. [Signal transduction mechanisms induced by epidermal growth factor receptor (EGFR) and their role in apoptosis regulation].
Ołdak M; Malejczyk J
Postepy Hig Med Dosw; 1999; 53(2):315-29. PubMed ID: 10355296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
